Joinn Laboratories(China)Co.,Ltd.
603127
Rankning i aktier
#3812
Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of... Joinn Laboratories (China) Co., Ltd. delivers a comprehensive suite of preclinical and non-clinical services to clients across the United States, China, and other international regions. The company's business is organized into three core operational areas. Its Non-Clinical Studies Services segment focuses on drug safety assessment, drug metabolism and pharmacokinetics analysis, and pharmacology and efficacy investigations. The Clinical Trial and Related Services division offers contract research organization (CRO) support for clinical trials, co-manages Phase I clinical research units, and provides bioanalytical services. Furthermore, the Sales of Research Models segment is involved in the design, production, breeding, and distribution of various research models, including non-human primates and rodents. Beyond these offerings, Joinn Laboratories also provides investment management and cell-based assay (CBA) services. Founded in 1995, the company is headquartered in Beijing, China.
Aktiekurs
$6.82
Marknadsvärde
$4.30B
Förändring (1 dag)
-6.30%
Förändring (1 år)
48.79%
Land
CN
Handel Joinn Laboratories(China)Co.,Ltd. (603127)
Kategori
Healthcare
P/B-tal för Joinn Laboratories(China)Co.,Ltd. (603127)
P/B-tal per October 2026 TTM: 3.72
Enligt Joinn Laboratories(China)Co.,Ltd. senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 3.72. I slutet av 2024 hade företaget ett P/B-tal på 1.52.
Historik för P/B-tal för Joinn Laboratories(China)Co.,Ltd. från 2012 till 2026
P/B-tal vid årets slut
| År | P/B-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 3.72 | 18.91% |
| 2025 | 3.13 | 105.36% |
| 2024 | 1.52 | -26.59% |
| 2023 | 2.08 | -45.67% |
| 2022 | 3.82 | -35.90% |
| 2021 | 5.96 | -68.75% |
| 2020 | 19.09 | 69.75% |
| 2019 | 11.24 | 34.73% |
| 2018 | 8.35 | 19.89% |
| 2017 | 6.96 | 63.38% |
| 2016 | 4.26 | -19.88% |
| 2015 | 5.32 | -23.41% |
| 2014 | 6.94 | -24.25% |
| 2013 | 9.17 | -15.74% |
| 2012 | 10.88 | 0.00% |
P/B-tal för liknande företag eller konkurrenter
| Företag | P/B-tal | Skillnad i P/B-tal | Land |
|---|---|---|---|
| 4.5801 | 23.06% |
US
|
|
| 3.0725 | -17.45% |
US
|
|
| 31.4903 | 746.08% |
US
|
|
| 4.9326 | 32.53% |
CN
|
|
| 6.8081 | 82.92% |
US
|
